
System Director, Non-Invasive Cardiology @montefioreNYC @einsteinmed @MonteHeart. Editor-in-Chief @PCVDJournal
New York, NY
Joined June 2017
- Tweets1.8K
- Following1.6K
- Followers2.6K
- Likes9.6K
Leandro Slipczuk retweeted
In CV imaging, it is essential to ensure that our reports are clinically meaningful, concise, and actionable.
As #CCTA evolves, so must our reports. In this editorial -- accompanying 2026 @Heart_SCCT interpretation and reporting guideline -- we highlight recent changes and future opportunities.
👏 @AnamWaheed05 tinyurl.com/4z6987ar
In >73,000 patients undergoing SPECT/PET MPI across 20 sites, ischemia remained prognostic across age groups and generally identified patients with better outcomes after early revascularization. The association was less clear in those ≥85. PET myocardial flow reserve may add useful physiologic information in older adults. @Piotr_JSlomka @krishnapatel888
Leandro Slipczuk retweeted
🆕📝 Dynamic pericoronary fat attenuation as a non-invasive marker of CAV progression after heart transplantation
🔗 tinyurl.com/2s3st2h3
@FTona63548
@Sciencedirect @ElsevierConnect
#Cardiology #CardioTwitter #CardioX #cardiovascular
Leandro Slipczuk retweeted
🆕✍️ Mitral annular disjunction: rethinking a controversial arrhythmic risk marker
🔗 tinyurl.com/53af5h7v
@Figliozzis @PatrizioLancel2
@Sciencedirect @ElsevierConnect
#CardioX #Cardiology #CardioTwitter
Leandro Slipczuk retweeted
jacc.org/doi/epdf/10.1016/j.…
New online today from our group at JACC Adv about LAAO
@EricSecemskyMD @CardioMDPhD
Leandro Slipczuk retweeted
🆕🔥✍️ Defining inflammation in cardiovascular risk: A complex challenge
🔗 tinyurl.com/4cp8rbjj
@ElsevierConnect @Sciencedirect
@amsterdamumc
#CardioTwitter #CardioX #Cardiology #Prevention
Leandro Slipczuk retweeted
Compartimos nuestra publicación en @PCVDJournal 👍. La experiencia utilizando la tomografía coronaria como estrategia de estudio inicial en SCA de bajo e intermedio riesgo!
Beyond stenosis: imaging phenotyping and risk stratification in nonobstructive coronary artery disease
shorturl.at/fI2bu
@pamelapina_s @AnnalisaFiltz @danilorenzatti @Ankurdee1 @JaideepBha35378 @Piotr_JSlomka @danielbermanmd @damini_dey
@MonteHeart @MontefioreNYC @EinsteinMed
Leandro Slipczuk retweeted
🆕✍️ Revascularization options for managing patients with multi-vessel coronary artery disease
🔗 tinyurl.com/5d27anzb
@Abingason @WCM_CTSurgery
@Sciencedirect @ElsevierConnect
#Cardiology #CardioX #CardioTwitter
Presented at #ESCCongress:
Among 16,808 adults without known cardiovascular disease, silent atherosclerosis was present in 57.1%, was detectable in early adulthood, and became more prevalent and extensive with age in a sex-dependent pattern. Full REACT trial results: nej.md/46gp1hP
@escardio

ALT A graph from the Original Article "Prevalence of Silent Atherosclerosis across Adult Life." The trial name, REACT, is in parentheses after the title. The graph shows a cross-sectional age pattern of silent atherosclerosis prevalence in men and women. The trial results are being presented at the European Society of Cardiology Congress 2026. The logo of the New England Journal of Medicine is at the bottom.
Leandro Slipczuk retweeted
🆕 ✍️ How do we move beyond one-size-fits-all in cardiovascular care?
🔗 tinyurl.com/2y5uxxja
@CardioMDPhD
🚨The latest issue of Progress in Cardiovascular Diseasesis here⬇️
🔗 tinyurl.com/ymtmzy4b
@ElsevierConnect
#CardioX #Cardiology #CardioTwitter
South Asian Cardiovascular Risk: Role of Coronary Artery Calcium Scoring and Computed Tomography Angiography. Outstanding work led by @DineshKalra and @virani_md just published in @JACCJournals
jacc.org/doi/10.1016/j.jacas…
@MontefioreNYC @MonteHeart @EinsteinMed
Leandro Slipczuk retweeted
Does a 0 calcium score mean you can skip the statin? This MESA study takes a closer look at how CAC may refine statin decisions in the PREVENT era. jacc.org/doi/10.1016/j.jacc.…
#JACC #cvPrev #ASCVD
The TRI-NOCA study reveals a groundbreaking "actionable process" that's changing lives for ANOCA patients. Read the full story to discover how this innovative approach is delivering improvements in quality of life. bit.ly/4q7Elqg
@CardioMDPhD
#ANOCA #HeartHealth
Leandro Slipczuk retweeted
Dear Faculty, Fellows, Residents and Friends
We invite you to join our @MonteHeart Grand Rounds
Tuesday Aug 4, 2026 with @CardioMDPhD
From 7:30 am EST – 8:30 am EST
Link to join: einsteinmed.zoom.us/j/915580…
Leandro Slipczuk retweeted
🆕📝 Coronary CT angiography for risk stratification among young adults: Prevalence of atherosclerosis and long-term outcomes
🔗 sciencedirect.com/science/ar…
@ArthurShiyovich @RonBlankstein @ghoshhajra
#YesCCT #CVprevention #Cardiology #CardioTwitter #CardioX
Leandro Slipczuk retweeted
From Jeddah to Delhi @IndiaCvt
Looking forward to an educational live case demonstration of coronary lithotripsy guided by intravascular ultrasound from @KFAFHCards with my IC colleague @DrAlsaiediAB
@mathur_a @SrihariNaiduMD @CardioMDPhD @DrSaritaRao2 @girishviswa @SukhNijjer @LAzzaliniMD
In partnership with @KR_Organisation
SAVE THE DATES: 1-2 August 2026 for New Delhi. @mirvatalasnag @AnkurKalraMD @mmamas1973 @PradeepYadavMD @SanjogKalra @KHERA_MD @chiragbavishiMD @Hragy @NishithChandra @mathur_a @PunamiyaKirti @AjayKirtane @crfheart @escardio
Happy to share our editorial, "Another Win for Lifestyle Medicine: Cardiac Rehabilitation–Based Therapy for ANOCA," published in JACC: Cardiovascular Interventions alongside the important SAMCRO randomized trial.
Despite the absence of obstructive coronary artery disease, patients with angina and no obstructive coronary arteries (ANOCA) often experience persistent symptoms, impaired quality of life, repeated testing, and uncertainty regarding their diagnosis. The challenge is no longer simply recognizing ANOCA but delivering effective, comprehensive treatment.
Congratulations to the investigators for advancing the field with high-quality randomized evidence, and to my co-authors Chip Lavie and Fabian Sanchis-Gomar for the opportunity to collaborate on this editorial.
Editorial: authors.elsevier.com/a/1nVvY…
Original research: sciencedirect.com/science/ar…
@CarlLavie31733 @MonteHeart @JACCJournals @ElsevierConnect
Leandro Slipczuk retweeted
Check out our new review on peripheral artery disease in @ESC_Journals. Great job by first author @FGaragoli! With terrific coauthors @CardioMDPhD, @DrMichaelShapir, and @MarcBonaca. @escardio #cardiology #cardiovascular #cardiotwitter #cardioX
Peripheral artery disease: advances in medical therapy. Read more in EHJ.
#PeripheralArteryDisease #MedicalTherapy #EHJ @ESCardio @ESC_Journals
doi.org/10.1093/eurheartj/eh…
Leandro Slipczuk retweeted
Proud to share our review, now published in @ESC_Journals!
PAD is an overlooked form of systemic atherosclerosis with a devastating prognosis.
Time to bring it to the forefront of CV prevention.
🔗 academic.oup.com/eurheartj/a…
@CardioMDPhD @DLBHATTMD @DrMichaelShapir @MarcBonaca


































